AARON HARRIS: Open Payments
NPI 1770858144 · COLORADO SPRINGS, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,437 in 100 payments from 37 companies in 2025. Trend: 2023 $4,662 · 2024 $4,235 · 2025 $2,437
Food & beverage: $2,411Education: $26
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 14 | $270 |
| Caris MPI, Inc. | 2 | $188 |
| Gilead Sciences, Inc. | 3 | $170 |
| PFIZER INC. | 8 | $160 |
| Regeneron Healthcare Solutions, Inc. | 1 | $125 |
| AstraZeneca Pharmaceuticals LP | 5 | $101 |
| Celgene Corporation | 4 | $100 |
| Merck Sharp & Dohme LLC | 4 | $93 |
| GlaxoSmithKline, LLC. | 4 | $85 |
| GENZYME CORPORATION | 3 | $79 |
Products named: MI CANCER SEEK, Trodelvy, EYLEA HD, ENHERTU, REBLOZYL, KISQALI, KEYTRUDA, XT CDX.
Industry payments across CO — which companies pay providers there.
